Drugging the cancer genome: New challenges of infrequent and combinatorial targets

被引:0
|
作者
Workman, Paul [1 ]
机构
[1] Inst Canc Res, Haddow Labs, Canc Res UK Ctr Canc Therapeut, Sutton SM2 5NG, Surrey, England
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:445 / 446
页数:2
相关论文
共 50 条
  • [31] Phenome-Genome Association Studies of Pancreatic Cancer: New Targets for Therapy and Diagnosis
    Narayanan, Ramaswamy
    CANCER GENOMICS & PROTEOMICS, 2015, 12 (01) : 9 - 19
  • [32] Challenges imposed by the complexity of cancer genome
    Ajani, Jaffer A.
    LANCET ONCOLOGY, 2013, 14 (08): : E291 - E292
  • [33] Cancer genome sequencing: the challenges ahead
    Heng, Henry H. Q.
    BIOESSAYS, 2007, 29 (08) : 783 - 794
  • [34] New Drug Targets for Genomic Cancer Therapy: Successes, Limitations, Opportunities and Future Challenges
    Workman, Paul
    CURRENT CANCER DRUG TARGETS, 2001, 1 (01) : 33 - 47
  • [35] Challenges in validating candidate therapeutic targets in cancer
    Settleman, Jeffrey
    Sawyers, Charles L.
    Hunter, Tony
    ELIFE, 2018, 7
  • [36] Drugging the R-loop interactome: RNA-DNA hybrid binding proteins as targets for cancer therapy
    Boros-Olah, Beata
    Dobos, Nikoletta
    Hornyak, Lilla
    Szabo, Zoltan
    Karanyi, Zsolt
    Halmos, Gabor
    Roszik, Jason
    Szekvolgyi, Lorant
    DNA REPAIR, 2019, 84
  • [37] The challenge of drugging undruggable targets in cancer: Lessons learned from targeting BCL-2 family members
    Verdine, Gregory L.
    Walensky, Loren D.
    CLINICAL CANCER RESEARCH, 2007, 13 (24) : 7264 - 7270
  • [38] Myeloma Researchers Gain Genome, New Targets, and New Concerns
    Brower, Vicki
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (14) : 1082 - 1085
  • [39] New targets in vascular biology and new challenges in vascular medicine
    Crea, Filippo
    EUROPEAN HEART JOURNAL, 2021, 42 (42) : 4285 - 4289